All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Ongoing | 2005-001574-27 | Sevoflurane on cardiac surgery: vantage to use during CEC | not-yet-due | |
| Ongoing | 2006-006210-14 | PIPERACILLIN/TAZOBACTAM PLUS TIGECYCLINE VS. PIPERACILLIN/TAZOBACTAM ALONE AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIC CANCER PATIENTS : A PROSPECTIVE, RANDOMISED, MULTI-CENTRE, STUDY. | not-yet-due | |
| Completed, but no date | 2007-006773-92 | Sodium Valproate in the treatment of medication overuse headache: a controlled randomized clinical trial. | bad-data | |
| Ongoing | 2008-002077-12 | ĀFenoldopam end Renal failureĀ (FENO-HSR) 'Fenoldopam e insufficienza renale acuta' (FENO-HSR) | not-yet-due | |
| Ongoing | 2008-008382-35 | Open , multicenter, randomized trial comparing two therapeutic approaches for the treatment of invasive fungal infections in neutropenic onco-hematologic patients.Empiric vs. ``presumptive`` (preempt... | not-yet-due | |
| Ongoing | 2009-017437-22 | MANAGEMENT OF PRIMARY AND SECUNDARY PERITONEAL CARCINOMATOSIS FROM COLO-RECTAL CANCER, RECURRENT OVARIAN CANCER AND ABDOMINAL SARCOMATOSIS BY CYTOREDUCTIVE SURGERY PLUS HYPERTHERMIC INTRAPERITONEAL CH... | not-yet-due | |
| Ongoing | 2009-017603-28 | Aprepitant for prevention of acute and delayed nausea and vomiting: a phase III, double-blind, randomized, palcebo-controlled trial in patients receiving a high-emetogenic dose of cyclophosphamide for... | not-yet-due | |
| Ongoing | 2011-002992-40 | PREvention of VENous Thromboembolism In Hemorrhagic Stroke patients PREvention of VENous Thromboembolism In Hemorrhagic Stroke patients | not-yet-due | |
| Ongoing | 2011-005487-13 | A phase II, multi-center, open label study of the clinical activity and safety of the BRAF-V600 inhibitor vemurafenib (PLX-4032) in previously treated patients with hairy cell leukemia (HCL) carrying... | not-yet-due | |
| Reported results | 2014-000693-18 | A PHASE II STUDY OF THE CLINICAL ACTIVITY AND SAFETY OF ACTINOMYCIN D IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA WITH NUCLEOPHOSMIN (NPM1) GENE MUTATION | 2016-07-19 | due-trials |
| Ongoing | 2015-002135-17 | Clinical efficay, pharmacokinetics and pharmacodynamics, and intra-subject variability of insulin Glargine U-300 vs Glargine U-100 in type 1 diabetes. Clinical efficay, pharmacokinetics and pharm... | not-yet-due | |
| Ongoing | 2016-002354-20 | EFFECTIVNESS OF WARFARIN REVERSAL USING INTRAVENOUS VITAMIN K AMONG HIP FRACTURE OLDER PERSONS: A RANDOMIZED CLINICAL TRIAL EFFECTIVNESS OF WARFARIN REVERSAL USING INTRAVENOUS VITAMIN K AMONG HI... | not-yet-due | |
| Ongoing | 2016-002725-11 | HEAD TO HEAD COMPARISON IN PHARMACOKINETICS AND PHARMACODYNAMICS, AND CLINICAL EFFICACY BETWEEN INSULIN GLARGINE U300 AND INSULIN DEGLUDEC IN TYPE 1 DIABETES HEAD TO HEAD COMPARISON IN PHARMACOKINE... | not-yet-due | |
| Ongoing | 2020-001475-33 | Treatment with COLchicine of patients affected by COVID-19: a Pilot Study Treatment with COLchicine of patients affected by COVID-19: a Pilot Study | not-yet-due | |
| Ongoing | 2020-005884-29 | EFFICACY AND SAFETY OF HEPARIN THROMBOPROPHYLAXIS IN PATIENTS WITH COVID-19 AND RESPIRATORY FAILURE: AN OPEN LABEL RANDOMIZED STUDY. The RESPECT-COVID (RESPiratory failure and hEparin Clinical Trial i... | not-yet-due | |
| Ongoing | 2021-001864-12 | VEMURAFENIB + RITUXIMAB (VR) AS A CHEMOTHERAPY-FREE ALTERNATIVE TO CLADRIBINE + RITUXIMAB (CDAR) IN FRONT-LINE HAIRY CELL LEUKEMIA (HCL): A PHASE-2 RANDOMIZED MULTICENTER TRIAL VEMURAFENIB + RITUXI... | not-yet-due |